Supplementary Figure 1 from Trametinib Thwarts Activation of Survival Pathways Induced by Pro-ferroptotic Drug Conjugate ACXT-3102 Resulting in Enhanced Pancreatic Cancer Cell Death
Year: 2025
Type: supplementary-materials
Abstract: Cell viability assays exhibiting ferrostatin-1 and deferoxamine (ferroptosis-specific inhibitors)-mediated blocking of ACXT-3102-induced cell death in PDAC (BxPC-3, AsPC-1, and PANC-1) cells.
Authors: Kumar S. Bishnupuri, Kenneth F. Newcomer, Qingqing Gong, Rony Takchi, Li Ye, Suwanna Vangveravong, Lauren Ross, Brian A. Van Tine, William G. Hawkins, Dirk Spitzer
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4416900413